Related Experiment Video
Updated: Jun 23, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Dialysis: preventing hypophosphatemia during pediatric CRRT
Zaccaria Ricci1, Claudio Ronco
1Department of Pediatric Cardiac Surgery, Bambino Gesù Hospital, Rome, Italy. zaccaria.ricci@fastwebnet.it
Insights
Adding phosphate to renal replacement therapy solutions is recommended for children. This supplementation significantly reduces hypophosphatemia, a common complication in pediatric continuous renal replacement therapy.
Area of Science:
- Pediatric Nephrology
- Critical Care Medicine
- Biochemistry
Background:
- Continuous renal replacement therapy (CRRT) is frequently used in critically ill children.
- Hypophosphatemia is a common and serious complication in pediatric patients undergoing CRRT.
- Phosphate levels can be depleted during CRRT due to the composition of replacement and dialysate fluids.
Discussion:
- This study addresses the clinical question of whether routine phosphate supplementation is warranted in pediatric CRRT.
- The findings suggest that proactive phosphate administration can mitigate a significant adverse event.
- The balance between phosphate administration and potential risks (e.g., hyperphosphatemia) needs careful consideration.
Key Insights:
- Phosphate supplementation in CRRT solutions effectively prevents hypophosphatemia in pediatric patients.
- Routine supplementation may improve patient outcomes by avoiding electrolyte disturbances.
- Early identification and management of electrolyte imbalances are crucial in pediatric critical care.
Outlook:
- Further research should investigate optimal phosphate dosing strategies and long-term effects.
- Guidelines for phosphate supplementation in pediatric CRRT should be considered.
- This approach could enhance the safety and efficacy of CRRT in pediatric populations.
Abstract:
A recent report showed that hypophosphatemia is common in children undergoing continuous renal replacement therapy, and that adding phosphate to the replacement and dialysate solutions significantly reduced the incidence of this complication. Should such supplementation be routinely performed?
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Continuous Renal Replacement Therapy
Chronic Kidney Disease III: Interprofessional Care
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis III: Nursing Management
